RNAi knockdown of GLI1 in human pancreatic adenocarcinoma cells
收藏官方服务：
资源简介：
RNAi knockdown of GLI1 in human pancreatic adenocarcinoma cells
应用场景：
创建时间：
2012-03-31
相关数据集
Table_1_GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma.xlsx
ObjectivePancreatic ductal adenocarcinoma (PDAC) is a highly malignant neoplasm with rising incidence worldwide. Gremlin 1 (GREM1), a regulator of bone morphogenetic protein (BMP) signaling, fine-tune
NIAID Data Ecosystem80
Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancer
Pancreatic cancer is characterized by a high frequency of cachexia, pain and neural invasion (N-inv). Neural damage is occurred by N-inv and modulates pain and muscle atrophy via the activation of ast
NIAID Data Ecosystem60
Application of non-invasive low-intensity pulsed electric field with thermal cycling-hyperthermia for synergistically enhanced anticancer effect of chlorogenic acid on PANC-1 cells
Most existing cancer treatments involve high-cost chemotherapy and radiotherapy, with major side effects, prompting effort to develop alternative treatment modalities. It was reported that the combina
NIAID Data Ecosystem50
Pancreatic Cancer Metastasis Treatment Market
The report offers Pancreatic Cancer Metastasis Treatment Market Dynamics, Comprises Industry development drivers, challenges, opportunities, threats and limitations. A report also incorporates Cost Tr
IMR REPORTS60
Additional file 7 of Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
Additional file 7: Supplementary Table S5. DAVID analysis of upregulated and downregulated genes in siMYEOV- (5A) and siDDX60L- (5B) transfected MiaPaCa2 and PANC-1 cells. DAVID, Database for Annotati
Figshare2024-02-15 更新50
